Best Life Sciences Companies in Tel Aviv District, Israel
The 62 best Life Sciences companies in Tel Aviv District, Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Lumen.
Our analysis of 50 Life Sciences companies
$2.2b in tracked funding; 75% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.
Ranked: Best Life Sciences companies in Tel Aviv District
| # | Company | Disclosed funding | Last round | Stage | Founder | Employees | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Advanced PNL Developer of self nano emulsifying drug delivery system for cannabis applications | — | — | Unfunded | Yaron v Founder & CEO | — | — | — | — |
| 2 | Althera Medical Developed local radiation therapy for the treatment of solid tumors | — | — | Unfunded | Kelson Itzhak Founder & Chairman | — | — | — | — |
| 3 | CannaMore Developer of cannabis-based solutions & products | — | — | Funding Raised | David Bassa CEO | — | — | — | — |
| 4 | CarboFix Develops orthopedic implants | — | — | Funding Raised | — | 63 | Cart FunctionalityWixSentry+12 | — | — |
| 5 | Cathway Medical Develops foley catheters for better cross-ability & navigation | — | — | Deadpooled | Eran Eilat Founder | — | — | — | — |
| 6 | Cell for Life Provider of cord blood banking services | — | — | Unfunded | Hagay Avisar Co-Founder | — | Master SliderPhotoSwipeWordPress+32 | — | — |
| 7 | Classeed Developer of a system protecting websites from aggressive AI scraping | — | — | Unfunded | Avi Klayman Managing Director | — | — | — | — |
| 8 | Derma Detect Developer of algorithm-based digital image analyzing solutions for the diagnosis of skin disorders | — | — | Funding Raised | Eugene Dicker Co-Founder | 18 | — | — | — |
Top 12 Life Sciences companies in Tel Aviv District
#1
Series B · Ramat Gan, Tel Aviv District · founded 2020 · 9 employees$12Mraised▾
Medical tech company offering ultrasound imaging devices using UV radiations. It uses hypercompute imaging technology for ultrasound imaging modality, based on geophysics algorithms and computational software interface with GPUs on the cloud.
- May 2026Series B$12M
#2
Series A · Ramat Hasharon, Tel Aviv District · founded 2019$15.1Mraised▾
Developer of targeted radiopharmaceuticals technologies to treat solid tumors. The company's research is in the development of molecules that serve as a vector for the targeted transfer of radioactive isotopes to cancerous tumors for diagnosis and targeted treatment of cancer.
- Jan 2026Series A$18M
- Oct 2024Series A$5.1M
- Dec 2021Series A$10M
#3
Series B · Ramat Gan, Tel Aviv District · founded 2014 · 20 employees$6.7Mraised▾
NitiNotes is focussed on developing non-surgical bariatric solutions for obesity issues. The company has received funding from Accelmed, an investment firm focused on value creation for medical device companies and technologies. As of Apr 2017, the company is operating from Peregrine's incubator and hasn't disclosed its product information and development details.
- Dec 2024Series B$9.3M
- Sep 2023Series B$10.1M
- Mar 2018Series A$6.7M
#4
Series B · Ramat Hasharon, Tel Aviv District · founded 2014 · 1 employees$77.5Mraised▾
Provider of metabolism tracker for a diet plan. The device is breath monitoring-based and provides personalized data on the mobile app, for carbohydrates and fats to monitor the body metabolism and diet plan for weight loss and overall fitness.
- Dec 2022Series B$62M
- Sep 2019Series B$8.5M
- Jul 2018Series A$7M
- Nov 2017Seed—
#5
Public · Ramat Gan, Tel Aviv District · founded 2009 · 183 employees$13.5Mraised▾
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases. The company is focusing on the development of proprietary, orally-administered, small molecule drugs for the treatment of multiple diseases. The company’s product pipeline includes RHB-204, RHB-104, RHB-102, and RHB-106 for H. pylori infections, Crohn's disease, Gastroenteritis gastritis, solid tumor, pancreatic cancer, Migraine, and other diseases.
- Jan 2024Post IPO$10M
- Oct 2023Post IPO$4M
- Aug 2023Post IPO$2.7M
- Sep 2020Grant (prize money)$300K
#6
Public · Ramat Hasharon, Tel Aviv District · founded 2016 · 14 employees$1.1Mraised▾
Developer of therapeutics for neurodegenerative diseases. It offers PrimeC, a unique formulation of a fixed-dose combination drug comprising ciprofloxacin and celecoxib for microRNA dysregulation, iron accumulation and neuroinflammation. It is also developing drugs for the treatment of Parkinson’s disease and Alzheimer’s disease.
- Jul 2024Grant (prize money)$189.1K
- Aug 2019Seed$1.1M
#7
Public · Holon, Tel Aviv District · founded 1993 · 20 employees$35.4Mraised▾
Compugen is a leading drug discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology and oncology. The company predictive platforms, algorithms, machine learning systems and other computational biology capabilities for the in silico (by computer) prediction and selection of product candidates, which are then advanced in its pipeline program.
#8
Series C · Ramat Gan, Tel Aviv District · founded 2008 · 27 employees$26.6Mraised▾
Medasense Biometrics is a medical device company that develops, PMD-200, a continuous and non-invasive pain-monitoring device. Its initial application will focus on the operating room, followed by the intensive care unit, and then within clinics and the home care environment to treat chronic pain patients.
- Sep 2020Series C$18M
- Mar 2016Series B$8M
- Nov 2010Series A—
- Dec 2008Seed—
#9
Deadpooled · Ramat Gan, Tel Aviv District · founded 2003 · 3 employees$43.1Mraised▾
Nutrinia is developing drug products to treat acute to chronic intestinal failure based on its proprietary Oral Insulin technology. These drug products will treat rare diseases of the gastrointestinal tract and impact short- and long-term morbidities of pre-term infants, children, and adults The Company is currently focused on supplementing pre-term and term infant formulas with insulin, which is present in natural mother's milk, but absent from infant formulas originated from powdered cow's milk and soy.
- Aug 2016Series D$30M
- Dec 2014Series C$12M
- Nov 2008Series A$1.1M
#10
Acquired · Ramat Gan, Tel Aviv District · founded 2017 · 18 employees$17.7Mraised▾
Developer of catheter-delivered heart valve therapies. It utilizes a proprietary rotational maneuver of specially designed arms which allows for the development of multiple medical devices for valve replacement and repair therapies. The lead product is the Transcatheter Mitral Valve Replacement system for the treatment of severe mitral regurgitation in patients with high surgical risk.
- 2021Series B$7.2M
- Aug 2020Series B$10.5M
#11
Series A · Ramat Gan, Tel Aviv District · founded 2015 · 9 employees$6Mraised▾
Developer of a micro-pancreas for diabetes treatment. This technology uses stem cell technology and tissue engineering to create a functional micro-pancreas that regulates insulin release based on blood glucose levels. The micro-pancreas is designed to improve insulin production, reduce cell mortality, and offer a less invasive implantation procedure compared to existing treatments. It aims to provide a long-term solution for managing diabetes by restoring beta-cell mass and eliminating the need for daily insulin injections.
- Jul 2021Series A—
- Sep 2020Grant (prize money)$2.9M
- Mar 2020Grant (prize money)$1.4M
- Oct 2019Series A$3.5M
#12
Series A · Ramat Gan, Tel Aviv District · founded 2004 · 25 employees$10Mraised▾
GIview develops devices for diagnosis and treatment of GI disorders. Colonoscope is designed for colorectal cancer screening. Its product, the Aer-O-Scope is a self-propelled, disposable colonoscope with 360° omni-directional visualization. The pneumatic self-propulsion mechanism uses balloons and low pressure CO2 gas for self-propelled intubation. It is connected to the Aer-O-Scope work station, which operates the disposable scanner.
- May 2006Series A$10M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Israel
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 267 Israel-affiliated papers.
- Ministry of Agriculture118
- Hebrew University of Jerusalem29
- Agricultural Research Organization25
- Tel Aviv University21
- Ben-Gurion University of the Negev19
- Mitochondrion1→5
- Gene1→18
- Plant disease resistance1→7
- Resistance (ecology)2→6
- Agriculture3→6
Where biotechnology is researched across Israel
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.